Tate & Lyle PLC announced on March 11 that Lars Frederiksen and Sybella Stanley have been appointed as non-executive directors, effective April 1.
“We are delighted that Lars and Sybella have agreed to join us,” said Peter Gershon, chairman of Tate & Lyle. “Lars’s considerable understanding of the global food ingredients industry and Sybella’s extensive commercial and financial experience will be of great benefit to the board as we progress the delivery of the group’s strategy.”
Frederiksen was chief executive officer (CEO) of Chr. Hansen Holding A/S from 2005 until his retirement in March 2013, leading a transformation of the business and a successful listing on the Copenhagen stock exchange during that period.
Prior to his appointment as CEO, Frederiksen held various management positions at Chr. Hansen, including executive vice-president, International Operations, executive vice-president, Bio Ingredients Division and executive vice-president, Dairy Ingredients Division. He is based in Denmark and has a portfolio of directorships, including serving as chairman of the board and of the Compensation and Nomination Committees of Matas A/S, non-executive director of Falck A/S and Rockwool A/S and chairman of the Danish Committee for Good Corporate Governance. Frederiksen will join the Remuneration, Corporate Responsibility and Nominations committees on his appointment.
Stanley is director of Corporate Finance at RELX Group plc (formerly Reed Elsevier Group plc), where she is responsible for global mergers and acquisitions. Stanley originally qualified as a barrister and before joining RELX Group in 1997, she was a member of the M&A advisory teams at Citigroup and later Barings. Based in the U.K., Stanley is a non-executive director of The Merchants Trust PLC, a member of the Department of Business, Innovation and Skills’ Industrial Development Advisory Board, a trustee of the Britten-Pears Foundation and a member of the Somerville College Oxford Development Board. Stanley will join the Audit and Nominations committees on her appointment.
Source: World Grain
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.